As of Oct. 21, South Carolinian firefighters administered opioid overdose antidotes to 200 people this year. The firefighters administered nasal naloxone, which can reverse the effects of an over...
Read More
Researchers at the University of Kentucky may have developed a multidisciplinary plan to treat those with opioid use disorder, a new study indicates. In 2018, the researchers treated 400 people wh...
Read More
Several Congressional members recently sent a letter to Timothy Shea, acting Drug Enforcement Administration (DEA) administrator, requesting a briefing on the agency’s management of the nation’s s...
Read More
CVS Health announced Thursday that they would be expanding their programs designed to prevent opioid misuse, a growing problem during the COVID-19 pandemic. In an effort to reach young people, CVS...
Read More
The National Institutes of Health recently awarded the University of Illinois at Chicago (UIC) College of Nursing a grant through its Helping to End Addiction Long-term Initiative. Nursing collegia...
Read More
Republican leaders in the House Energy and Commerce Committee asked the U.S. Food and Drug Administration why it approved a label change for OxyContin in 2001. Committee members Reps. Greg Walden ...
Read More
New York Gov. Andrew Cuomo announced Tuesday the state would provide nearly $853,000 in funding for healthcare providers in five regions to expand mobile addiction treatment services. The federal ...
Read More
In a new settlement, the largest generic opioid manufacturer in the United States will pay $1.6 billion into a trust that will go towards abating the opioid crisis, attorneys general from several stat...
Read More
Since the start of the COVID-19 pandemic, scientific and medical journals have received thousands of papers, but many are substandard and were rushed to publication, an ethicist warned recently in the...
Read More
The National Institutes of Health (NIH) recently awarded a coalition of 11 Californian academic institutions and their community partners a $4.1 million grant to address COVID-19 in areas disproportio...
Read More
A recent study looking at pain among cannabis users has found that regular cannabis use doesn’t appear to increase pain sensitivity – unlike long-term opioid use. The study, done by doctoral s...
Read More
The U.S. Food and Drug Administration issued its finalized guidance for drug companies hoping to create new medicines to treat opioid use disorder. Previously, the FDA had opened its guidance up f...
Read More
A new report from the Office of the Inspector General of the U.S. Department of Health and Human Services had found that despite access to naloxone for Medicaid beneficiaries expanding, Medicaid pays ...
Read More
The South Carolina Department of Health and Environmental Control (DHEC) recently issued a health advisory to provide prescribers and prescription drug dispensers with preventive strategies to decreas...
Read More
Emergent BioSolutions, a maker of naloxone, announced its support for new Canadian guidelines for pharmacists when it comes to prescribing opioids. As part of a national movement to combat the opi...
Read More
U.S. Sen. Jerry Moran (R-KS) has announced he is joining a bipartisan group of senators calling on the Health Resources and Services Administration (HRSA) to address pharmaceutical companies’ underm...
Read More
New York Gov. Andrew Cuomo announced Thursday his administration’s Department of Financial Services (DFS) had filed a fraud claim against Johnson & Johnson for its part in the opioid epidemic. J...
Read More
Officials with the U. S. Food and Drug Administration say they have issued warning letters to 17 websites for illegally selling opioids online. The unapproved and misbranded opioids include those ...
Read More
New Jersey residents can get free naloxone at more than 320 participating pharmacies across the state from Sept. 24-26, Gov. Phil Murphy Human Services Commissioner Carole Johnson announced Wednesday....
Read More
The U.S. House Energy and Commerce Committee recently advanced legislation that would require drug manufacturers and distributors to report and halt suspicious orders of controlled substances. Unde...
Read More